Markets:

Overview

News

Currencies

International

Treasuries

Compugen Ltd. - Ordinary Shares (NQ:CGEN)

2.245 -0.105 (-4.47%)

Streaming Delayed Price Updated: 2:54 PM EDT, Aug 3, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Compugen Ltd. - Ordinary Shares

< Previous 1 2 3 4 5 6 Next >

Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2022 ↗

August 05, 2022

Upgrades

Via Benzinga

Compugen: Q2 Earnings Insights ↗

August 04, 2022

Compugen (NASDAQ:CGEN) reported its Q2 earnings results on Thursday, August 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Earnings Preview For Compugen ↗

August 03, 2022

Compugen (NASDAQ:CGEN) is set to give its latest quarterly earnings report on Thursday, 2022-08-04. Here's what investors need to know before the announcement. Analysts estimate that Compugen will...

Via Benzinga

Recap: Compugen Q1 Earnings ↗

May 16, 2022

Compugen (NASDAQ:CGEN) reported its Q1 earnings results on Monday, May 16, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Earnings Scheduled For May 16, 2022 ↗

May 16, 2022

Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

February 04, 2022

On Friday, 209 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Meta Platforms (NASDAQ:FB) was the largest firm on a market cap...

Via Benzinga

This Technology Stock Surged 235%; Here Are 77 Biggest Movers From Friday ↗

July 25, 2022

Gainers

Via Benzinga

Earnings Outlook For Compugen ↗

May 13, 2022

Compugen (NASDAQ:CGEN) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to know before the announcement. Analysts estimate that Compugen will report...

Via Benzinga

The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves ↗

May 10, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

World Markets News For Friday ↗

March 18, 2022

Buoyant global markets are closing the week and one good performer, Vir Biotech, today gained an impressive 6.09%.

Via Talk Markets

Gold up, Stocks down ↗

March 10, 2022

The gold market came back to life after a one-day hiatus.

Via Talk Markets

Stocks That Hit 52-Week Lows On Wednesday ↗

April 20, 2022

On Wednesday, 160 companies hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: Walt Disney (NYSE:DIS) was the largest firm by market cap to set a new...

Via Benzinga

Inflation inflating ↗

February 10, 2022

The Fed will be raising interest rates soon and this will chop the appeal of investments in more vulnerable yield plays.

Via Talk Markets

A News Blizzard ↗

February 04, 2022

Markets are still down despite very encouraging news in January when 467,00 new hires got jobs.

Via Talk Markets

The Last Day In January ↗

January 31, 2022

The market is suspicious of the moves up to right matters.

Via Talk Markets

Drug Troubles ↗

January 28, 2022

The drug sector has both good news and bad.

Via Talk Markets

World Markets News ↗

January 20, 2022

Today oil and gas inventories were seen as higher than expected while potential prices fell, both bullish.

Via Talk Markets

Wednesday File ↗

January 19, 2022

It sound odd but the real threat to markets is slowing Chinese growth which fell to 4% in Q4 from double that earlier last year.

Via Talk Markets

Chopped Stocks ↗

January 18, 2022

The day's theme is sell tech and buy banks.

Via Talk Markets

Early Monday Report - More Moves Out Of China ↗

January 09, 2022

Before it even turned Monday in the West, China insurers are feeling the heat.

Via Talk Markets

Start Of 2022 ↗

January 03, 2022

Mohammed El Erien predicts that the Fed will be slamming on the brakes this year.

Via Talk Markets

Markets Inching Up ↗

December 28, 2021

As both China and the SEC are cracking down on Variable Interest Entities raising funds as if they were stocks, these are now in the dumps.

Via Talk Markets

A Bit Of Good News ↗

December 22, 2021

US growth figures for Q3 were up from forecasts of 2.1% at 2.3% but well down from the prior quarter level of 6.7%.

Via Talk Markets

Dreaming Of A Red Christmas ↗

December 20, 2021

The stock market is reacting with lots of selling to the weekend's news.

Via Talk Markets

Raising Rates ↗

December 16, 2021

The Bank of England raised its interest rate to 0.25%, setting a pattern for other countries.

Via Talk Markets

Uncertain Times ↗

December 15, 2021

The UK inflation rate last month was 5.1%, not a good omen.

Via Talk Markets

To sell or not to sell? ↗

December 14, 2021

Pfizer says its covid pill is 90% effective. PFE got higher target prices from Berenburg and Mizuho

Via Talk Markets

Omicron Surge ↗

December 09, 2021

The seemingly good level of joblessness at a mere 184,000 turns out to be less wonderful than it appears, at the lowest since 1969.

Via Talk Markets

What A 1920s Gang Should Have Known About Trading ↗

December 09, 2021

A support line is a price level where a stock historically stops declining. It can be a flat line all at one price, or it can be a trend line that gradually moves in one direction.

Via Talk Markets

Friday Markets Coverage ↗

November 19, 2021

Today markets are suffering alongside Austria which locked down against Covid-19 again.

Via Talk Markets

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.